A proteomic signature for dementia with Lewy bodies

INTRODUCTION: We sought to determine if a proteomic profile approach developed to detect Alzheimer's disease would distinguish patients with Lewy body disease from normal controls, and if it would distinguish dementia with Lewy bodies (DLB) from Parkinson's disease (PD). METHODS: Stored pl...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Alzheimers Dement (Amst)
Auteurs principaux: O'Bryant, Sid E., Ferman, Tanis J., Zhang, Fan, Hall, James, Pedraza, Otto, Wszolek, Zbigniew K., Como, Tori, Julovich, David, Mattevada, Sravan, Johnson, Leigh A., Edwards, Melissa, Graff-Radford, Neill R.
Format: Artigo
Langue:Inglês
Publié: Elsevier 2019
Sujets:
Special Section: Blood-Based Biomarkers for Alzheimer's Disease & Related Dementias. (Editor: Henrik Zetterberg)
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6424013/
https://ncbi.nlm.nih.gov/pubmed/30923734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2019.01.006
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires